A detailed history of Prospect Financial Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Prospect Financial Group LLC holds 1,138 shares of ABBV stock, worth $266,292. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,138
Previous 1,136 0.18%
Holding current value
$266,292
Previous $211 Million 24.96%
% of portfolio
0.26%
Previous 0.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

BUY
$184.85 - $231.54 $369 - $463
2 Added 0.18%
1,138 $263 Million
Q2 2025

Aug 07, 2025

BUY
$170.16 - $206.27 $9,528 - $11,551
56 Added 5.19%
1,136 $211 Million
Q1 2025

May 06, 2025

BUY
$169.2 - $216.66 $182,736 - $233,992
1,080 New
1,080 $226 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Prospect Financial Group LLC Portfolio

Follow Prospect Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospect Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prospect Financial Group LLC with notifications on news.